Camblong Jurgi 4
4 · SOPHiA GENETICS SA · Filed Jul 8, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) Executive Chairman Jurgi Camblong Sells Shares
What Happened
Jurgi Camblong, Executive Chairman and Director of SOPHiA GENETICS SA (SOPH), sold 17,685 shares in an open-market transaction on July 7, 2026 at $5.28 per share, generating proceeds of $93,327. This was a sale (not a purchase) and was executed to cover tax withholding obligations tied to vested restricted stock units.
Key Details
- Transaction date and price: July 7, 2026 — 17,685 shares sold at $5.28 each.
- Total proceeds: $93,327 (gross).
- Shares owned after transaction: Not disclosed in this filing.
- Footnote: The sale was to satisfy tax withholding from RSUs that vested on July 3, 2026 and was executed under a pre-established Rule 10b5-1(c) trading plan; trades were non-discretionary.
- Filing timeliness: Report filed July 8, 2026 (appears timely under Form 4 reporting rules).
Context
Sales to cover tax withholding on vested awards are common and generally considered routine rather than a directional vote on the company. The use of a pre-established 10b5-1 plan indicates the trade was automatic and not an ad hoc decision by the insider.
Insider Transaction Report
Form 4
Camblong Jurgi
DirectorExecutive Chairman
Transactions
- Sale
Ordinary Shares
[F1]2026-07-07$5.28/sh−17,685$93,327→ 3,541,122 total
Footnotes (1)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
Signature
/s/ Elimara Brunetto as Attorney-in- Fact for Jurgi Camblong|2026-07-08